What Researchers Did
Doctors treated three patients with severe sudden hearing loss using a new steroid injection called dexamethasone palmitate, given alongside systemic steroids and hyperbaric oxygen therapy.
What They Found
This case report describes three patients with profound sudden sensorineural hearing loss who received six sessions of intratympanic dexamethasone palmitate along with systemic steroids and hyperbaric oxygen therapy. Two of the three patients showed substantial improvement in hearing thresholds and speech discrimination within three months. The third patient, who presented late, showed no recovery. No adverse effects such as pain, inflammation, or tympanic membrane complications were observed in any patient.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a case report of only three patients with no control group, so the individual contribution of dexamethasone palmitate, systemic steroids, and hyperbaric oxygen cannot be separated, and the findings cannot be generalized.